Interaction between angiogenin and the p53 TAD2 domain in cancer cells can inhibit the function of the p53 tumor suppressor and promote cell survival. Based on a model structure using NMR and mutational analysis, positively charged 31 RRR 33 and 50 KRSIK 54 motifs of human angiogenin were identified as p53-binding sites that could interact with negatively charged D48/E51 and E56 residues of the p53 TAD2 domain, respectively. These results suggest that 31 RRR 33 and 50 KRSIK 54 motifs of human angiogenin might play a critical role in the regulation of p53-mediated apoptosis and angiogenesis in cancer cells. This study identifies potential target sites for screening angiogenin-specific inhibitors that could not only inhibit p53 binding but could also simultaneously inhibit cell binding, internalization, DNA binding, and nuclear translocation of human angiogenin.
inhibits phosphorylation of p53 by interacting with the acidic N terminus transcription-activation domain 2 (TAD2 domain, residues D48-E56) of p53, thus enhancing p53-mdm2 association and subsequent p53 ubiquitination [20] . Thus, inhibiting the interaction between hAng and p53 might be critical for the regulation of p53-mediated apoptosis of cancer cells. To provide a clue to screen and design hAng-specific inhibitor, it is important to identify p53-binding site of hAng and perform structural studies for p53 TAD2 domain. In this study, the p53-binding site of hAng was identified. A model structure of the hAng-TAD2 complex based on NMR experiments showed that the main p53-binding site of hAng was identical to the heparin-binding site known to be critical for cell binding and internalization of hAng as well as DNA binding [21] . Results of this study will enable us to find applicable methods for screening hAngspecific inhibitors using NMR competition mode.
Materials and methods

Protein expression and purification
Recombinant catalytic domain of hAng (residues Q1-P123) was prepared as described in a previous report [21] . Briefly, Nterminal 6xHis-tagged hAng was overexpressed in E. coli BL21(DE3) strain using pET28a expression vector system. Inclusion bodies of the protein were denatured in a buffer containing 7 M guanidine hydrochloride, 50 mM Tris-HCl, and 20 mM DTT at pH 8.0. The protein was refolded using a rapid dilution method in a refolding buffer (20 mM Tris-HCl, 300 mM NaCl, 20 % glycerol, 5 mM b-mercaptoethanol, pH 7.5) at 4°C and purified using Ni-nitrilotriacetic acid resin and size-exclusion chromatography. Detailed refolding and purification steps were described in a previous report [21] .
p53 N terminus (residues M1-A70) and mdm2 (residues S17-N125) were cloned into pGEX4T-1 expression vector using BamHI and XhoI as restriction enzymes. The plasmid was transformed into E. coli BL21 strain. Cells were grown to an OD 600 of 0.6-0.8 at 37°C and protein with GST fusion at its N terminus was induced by the addition of 0.5 mM IPTG at 18°C. After overnight growth, cells were harvested at 4°C. These cells were suspended in lysis buffer (PBS buffer containing 5 mM EDTA, 1 mM PMSF, and 100 mM NaCl, pH 7.4) and sonicated on ice followed by centrifugation at 50 000 g for 30 min. Proteins were purified from the supernatant using GST affinity column. After cleavage of GST fusion protein by thrombin digestion, GST was removed by size-exclusion chromatography.
NMR spectroscopy
Avance II 800 MHz and 900 MHz spectrometers (Bruker) were used for NMR experiments in this study. Backbone resonances of hAng were assigned based on previous results [21, 22] . To measure binding affinity of p53 TAD2 peptide to hAng, binding curves were obtained from two- N-labeled hAng were acquired at 1 : 1 molar ratio of hAng to p53 TAD2-Cys-MTSL peptide in oxidized and reduced states. The reduced state was generated by incubation with 1.5 mM ascorbic acid for 1 h at room temperature. Carr-Purcell-Meiboom-Gill sequence (CPMG) experiment of p53 TAD2 short peptide was acquired at 30°C with a total spinlock time of 200 ms (D = 1 ms, n = 100).
Calculations of hAng-p53 TAD2 peptide model structure
Protein-protein docking simulation was performed by handling each protein as rigid body. To model structures for angiogenin and p53, two RCSB-deposited structures of 4AOH and 2GS0 were employed, respectively. Computation for model building is performed with CYANA and AMBER programs. Ambiguous distance restraints were prepared as active and passive residues according to the degree of chemical shift changes in 2D 1 H- 15 N HSQC based on the definition of HADDOCK [24] . In angiogenin, active residues were 4, 7, 33, 50, and 51 while passive residues were 5, 8, 32, 34, and 49. On the other hand, residues of 47, 50, 53, 54, and 56 in p53 were assigned as active while residues of 46, 48, 49, 52, and 55 were assigned as passive. Distances from an active residue in a protein and all active or passive residues from the other protein were restrained by an upper limit of 4 A. Distance pairs were prepared in an ambiguous way between all heavy atoms in two residues. To confine each protein as rigid body, artificial distance restraints between two Ca atoms within 15 A in a structure were prepared with an upper limit of 15.5 A. Except for active and passive residues, two Cb atoms within 15 A were restrained with 15.5 A as well. With distance restraints, CYANA with 30 000 steps of torsion angle dynamics calculated 300 structures [25, 26] . By omitting restraints showing significant violations in 100 structures with the lowest target function, CYANA runs were repeated four times. The resulting 100 structures were further refined with all-atom force field and generalized-Born implicit solvent using AMBER 14 [27] . After minimizing each structure with 1500 steps and simulating annealing method of 1 ns followed by gradually changing temperature 0 to 1000 and 1000 to 0 K, the structure was minimized again with 1500 steps. Clustering of AMBER-refined 100 structures based on their backbone root mean square deviations generated 46 structures with low AMBER energies. Force field and implicit solvent model used ff14SB and igb = 8 option, respectively. GPU version of pmemd code was used to accelerate calculations [28] .
Results and Discussion
A previous study has suggested that hAng can form ternary complex with p53 and mdm2 [20] . Especially, the TAD2 domain of p53 N terminus participates in its interaction with hAng. To examine whether hAng could directly bind to p53 N terminus or mdm2, chemical shift perturbations of backbone signals of 15 Nlabeled hAng in the presence of unlabeled p53 N terminus or mdm2 were examined. Results are shown in Fig. S1 . Several backbone signals of hAng were shifted when the amount of unlabeled p53 N terminus added was increased (Fig. S1A) . However, the addition of mdm2 did not affect backbone signals of hAng (Fig. S1B ). This indicates that hAng can directly bind to p53 N terminus, but not mdm2. It is well known that the N-terminal TAD1 domain (residues E17-L25) of p53 can interact with mdm2 and regulate apoptosis of cells [29] . Taken together, these data suggest that hAng can bind to p53 TAD2 domain while p53 TAD1 domain can also interact with mdm2. As a result, a p53 ternary complex is formed [20] . To confirm that hAng could bind to p53 N terminus, chemical shift perturbations of backbone signals of 15 N labeled p53 N terminus in the presence of unlabeled hAng were examined. Results are shown in Fig. S2 . Backbone signals of p53 N terminus were perturbed by the addition of hAng based on BMRB data of p53 N terminus (BMRB number: 17760) [30] . Results showed that the TAD2 sequence was included in most amino acids perturbed by the addition of hAng, but not TAD1 sequence, suggesting that hAng could directly interact with the TAD2 domain of p53. Therefore, p53 TAD2 peptide (sequence 39 
AMDDLMLSPD-DIEQWFTED
57
) containing TAD2 domain (residues D48-E56) of p53 was used for interaction study with hAng. Such TAD2 peptide has been previously used for interaction study of p53 with antiapoptotic Bcl-2 family proteins [23] .
To identify the p53-binding site of hAng, 1 H-15 N chemicals shifts of backbone signals of hAng were observed in the absence or presence of TAD2 peptide. Differences in chemical shifts between the two conditions (in the absence or presence of TAD2 peptide) and TAD2-binding sites are shown in Fig. 1 . Chemical shifts of backbone signals of hAng were assigned based on previous reports [21, 22] . According to chemical shift perturbation data, most amino acids located on the first helix (a1) were mainly perturbed by TAD2 binding (Fig. 1C) . In addition, chemical shifts of positively charged R32 and R33 residues on the second helix (a2), K50 and R51 residues on the third helix (a3), and V113 residue behind the a1 helix were remarkably perturbed by TAD2 binding. Backbone signals around V113 residue appeared to be affected by secondary effect of perturbation of a1 helix. These data suggest that negatively charged TAD2 peptide can bind to two positively charged motifs (   31   RRR   33 motif on a2 helix and 50 KRSIK 54 motif on a3 helix) of hAng across a1 helix.
In previous reports, these motifs of hAng have been suggested as critical sites for heparin binding, internalization, nuclear translocation, and DNA binding [21, 31] . In particular, the 50 KRSIK 54 motif of hAng is major binding site for heparin and DNA [21] .
Dissociation constant (K d ) was determined using chemical shift perturbation data from 1 H-15 N backbone signals of hAng with increasing concentration of TAD2 peptide (Fig. S3) . K d was 117.0 AE 6.6 lM based on average values of three residues (T7, R33, K54) located on the binding surface of a1, a2, and a3 helices perturbed by TAD2 peptide. K d value (220.0 AE 30.6 lM) was increased approximately twofold in 150 mM NaCl compared to 100 mM NaCl, suggesting that ionic strength condition might be critical for the formation of hAng-TAD2 complex.
Due to difficulty in detecting intermolecular NOE signals between hAng and TAD2 peptide, we were unable to build a model structure using intermolecular NOE values. The hAng-TAD2 complex might have an intermediate exchange rate which is difficult to detect in NMR time scale due to linebroadening [23] . Moreover, the hAng-TAD2 complex was precipitated at low salt condition. It seems that the neuteralization of positively charged hAng by increasing the concentration of negatively charged TAD2 peptide facilitates the precipitation. Thus, to investigate structural change in TAD2 peptide by hAng binding, [ (Fig. S4) , suggesting that disordered TAD2 peptide became helical in structure after hAng binding. In general, TAD2 peptide is intrinsically disordered. It becomes helical in structure after binding to its binding partners [23, 32] . The structure of hAng-TAD2 complex was modeled using chemical shifts perturbations of backbone signals of hAng after adding TAD2 peptide. The model structure of hAng-TAD2 complex was generated by docking simulation and refined using CYANA and AMBER programs (Materials and methods, Fig. S5) . A complex structure from 10 lowest energy structures is represented by ribbon diagram (Fig. 2) . As expected, TAD2 peptide interacted with a2 and a3 helices across a1 helix of hAng. Negatively charged D48/E51 and E56 residues of TAD2 peptide formed salt bridges with positively charged R32 and K54 residues, respectively. The side chain of W53 residue of TAD2 is located on the hydrophobic surface of a1 helix of hAng (Fig. 2B) . To confirm the orientation of TAD2 peptide of the model structure, PRE experiment was performed using MTSL attached to the C terminus of TAD2-Cys peptide (TAD2-Cys-MTSL peptide). Differences in backbone signal intensities from 1 H-15 N HSQC spectra of hAng were calculated in the presence of TAD2-Cys-MTSL peptide in both oxidized and reduced states. Signal intensities of amino acids on a1 and a3 helices and S74 and S75 residues located behind the a3 helix were significantly decreased. However, amino acids on a2 helix were less affected (Fig. S6 ). This suggests that the C terminus of TAD2 peptide is toward a1 and a3 helices of hAng.
To validate the model structure, chemical shifts perturbations of hAng were measured with various p53 TAD2 mutants (Fig. 3) . When acidic residue D48 or E51 of p53 TAD2 peptide was mutated to alanine, chemical shifts perturbations of the N-terminal a1 helix region of hAng were slightly decreased. However, when both residues were mutated together (TAD2 D48A/E51A double mutant), chemical shifts perturbations of the overall region of hAng were significantly decreased. This indicates that the two salt bridges between the R32 residue of hAng and D48/E51 residues of p53 TAD2 peptide are critical for formation of the hAng-p53 complex. E56A mutant of TAD2 decreased chemical shifts perturbations of hAng as much as D48A/E51A double mutant of TAD2, suggesting that the salt bridge between the E56 residue of TAD2 peptide and the K54 residue of hAng might have a crucial role in the formation of hAng-p53 complex. In addition, W53A mutant of TAD2 remarkably decreased chemical shifts perturbations of the N-terminal region of hAng. This reflects that the W53 residue participates in the interaction of TAD2 with the [33] . In the case of hAng, the 50 KRISK 54 motif of hAng has been suggested to be the major binding site for heparin and DNA binding [21] . The 31 
RRR
33 motif of hAng also participates in their binding [21, 34] . To confirm p53 TAD2-binding sites of hAng, hAng (R31A/R32A/R33A), and hAng (K50Q/R51A/K54Q) mutants used in a previous report [21] were introduced and their backbone signal changes were observed after the addition of TAD2 peptide. Backbone signals of both mutants were less perturbed by the addition of TAD2 peptide than those of wild-type hAng (Fig. S7) . This reflects that both 31 
33 and 50 KRISK 54 motifs are involved in the interaction with p53 TAD2 domain. Moreover, hAng K50Q/R51A/K54Q mutant interacted with the TAD2 peptide less effectively than wild-type hAng and hAng R31A/R32A/R33A mutant (Fig. S7C) . This suggests that the 50 KRISK 54 motif is more important than the 31 RRR 33 motif for the interaction of hAng with p53 TAD2 domain. Binding affinities of both hAng R31A/R32A/R33A and hAng K50Q/R51A/K54Q mutants were decreased compared to those of the wild-type (Table S1 ). In particular, the binding affinity of hAng K50Q/R51A/K54Q mutant (K d = 539.3 AE 23.4 lM) was lower than that of hAng R31A/R32A/R33A mutant (K d = 228.3 AE 28.6 lM). This also indicates that the 50 KRSIK 54 motif is more important than the 31 
33 motif for the interaction of hAng with p53 TAD2 domain. These data are well consistent with HSQC spectra of hAng mutants (Fig. S7) and the model structure that both motifs participate in the interaction of hAng with TAD2 peptide (Fig. 2) . Moreover, TAD2 peptide does not inhibit RNase activities of RNase A or hAng (data not shown), suggesting that the TAD2 peptide does not bind to the active site of hAng and the binding of TAD2 peptide on hAng does not significantly affect the structural change in the active site of hAng. Therefore, the 50 KRISK 54 motif of hAng is the main site not only for p53 binding but also for heparin and DNA binding [21] . In the previous reports [21, 31, 34] , both 31 
33 and 50 KRISK 54 motifs participate DNA binding and internalization and nuclear translocation of hAng, which are important processes for the regulation of angiogenic factors. Thus, both motifs might play a critical role in the regulation of angiogenesis as well as p53-mediated apoptosis through p53 binding.
As mentioned above, the 50 KRISK 54 motif of hAng has been suggested to be the main heparin-binding site [21] . Thus, if the 50 KRISK 54 motif of hAng is involved in both heparin and p53 TAD2 binding, the complex of hAng-p53 could be disrupted by the addition of heparin due to competition with heparin. To observe the dissociation of p53 from the hAng-p53 complex after the addition of tetrasaccharide heparin, backbone signal changes of 15 N labeled p53 N terminus were monitored in the presence of unlabeled hAng. Results are shown in Fig. S8 . The direction of chemical shifts changes of hAng-p53 complex was moved to free state of p53 N terminus after the addition of tetrasaccharide heparin (Fig. S8B) . This indicates that the p53 N terminus is dissociated from the complex due to competition with heparin binding. These results also suggest Designing hAng-specific inhibitor targeting its RNase active site is difficult due to similar catalytic mechanism between hAng and RNase A [35] . (Fig. S9) . To test whether TAD2 short peptide could work as a spy molecule, tetrasaccharide heparin was used as a reference inhibitor. Proton signal of indole group of W53 residue of TAD2 short peptide was monitored by 1 H CPMG NMR experiment in a competition mode (Fig. 4) . In the presence of hAng, the intensity of proton signal of the indole group was significantly decreased compared to that of free state TAD2 short peptide. Its maximum chemical shift value was shifted to down field, forming a complex of hAng with TAD2 short peptide. When tetrasaccharide heparin inhibitor was added to the complex, the signal intensity was recovered and the chemical shift of the peptide returned to that of free state peptide (Fig. 4, blue In the presence of hAng, the intensity of proton signal of the indole group was significantly decreased compared to that of free state TAD2 short peptide. Its maximum chemical shift value was shifted to down field, forming a complex of hAng with TAD2 short peptide. When tetrasaccharide heparin inhibitor was added to the complex, the signal intensity was recovered and the chemical shift of the peptide returned to that of free state peptide (blue and green lines).
at S15 residue of p53. It enhances interaction with mdm2 and ubiquitination of p53, resulting in loss of function and degradation of p53 [20] motif of hAng is identified as a signal peptide for its nuclear translocation [31] . Results of the present study and previous reports suggest that both motifs play crucial roles in various functions of hAng, including apoptosis, regulation of angiogenic factors, metastasis, and cell invasion of tumor cells through p53 binding, DNA binding, cell binding, and internalization of endogenous hAng, respectively. Therefore, from cell surface to the nucleolus, both motifs might be key sites to inhibit hAng's functions, specifically in cancer cells.
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Additional Supporting Information may be found online in the supporting information tab for this article: Fig. S1 . HSQC spectra of hAng in the presence of p53 N terminus (A) or mdm2 (B). Fig. S2 . HSQC spectra of p53 N terminus in the absence or presence of hAng. Fig. S3 . Titration curves of hAng with TAD2 peptidein 20 mM Bis-tris and 100 mM (A) and 150 mM (B) NaCl(pH 6.0)at 25°C. Fig. S4 . NOESY spectrum of TAD2 peptide in the presence of hAng. 1 mM) by the additionof tetrasaccharide heparin (0.2 mM, green color). Fig. S9 . Chemical shifts changes of hAng by the addition of TAD2 short peptide in 20 mM sodium phosphate, 50 mM NaCl, and 5 mM sodium acetate, pH 6.0, at 25°C (blue color, 0.1 mM protein only; red and green colors, in the presence of 0.1 mM and 0.4 mM TAD2 short peptide, respectively). Table S1 . K d values for wild-type hAng, hAng R31A/ R32A/R33Amutant, and hAng K50Q/R51A/K54Q mutant using NMR titration in the presence of 100 mM NaCl as described in Fig. S3 . K d values were obtained from average values of three residues (Y6, T7, and R51 residues located on a1 and a3 helices for hAng R31A/R32A/R33A mutant; T7, R32, and R33 residues located on the a1 and a2 helices for hAng K50Q/R51A/K54Q mutant).
